**Summary**
Eco Animal Health Group PLC, a global animal health company listed on AIM (EAH), announced on August 29, 2025, the granting of share awards to its Executive Directors under two incentive plans
1. **Long Term Incentive Plan (LTIP)**
**374,318** conditional share options (0.55% of issued share capital) were awarded to CEO David Hallas (215,106) and CFO Chris Wilks (159,212).
These awards are subject to performance conditions tied to Total Shareholder Return (TSR) and Research and Development (R&D) targets.
Vesting occurs after a three-year period, provided performance conditions are met.
2. **Deferred Bonus Plan (DBS)**
**60,295** share options (0.09% of issued share capital) were granted, with David Hallas receiving 35,472 and Chris Wilks receiving 24,823.
These awards relate to the deferral of 33% of the annual bonuses earned for the financial year ended March 31, 2025.
The DBS includes malice and clawback provisions, with vesting after three years.
The awards were granted at a nominal cost of 5p per share and are part of the Company’s remuneration strategy to align executive interests with long-term shareholder value. Further details are available in the Company’s 2025 Annual Report.
**Key Contacts**
**Eco Animal Health Group PLC** David Hallas (CEO), Christopher Wilks (CFO)
**Nominated Adviser & Joint Broker** Singer Capital Markets
**Joint Broker** Investec
**Financial PR** ICR Healthcare
Eco Animal Health is a leader in veterinary pharmaceuticals, specializing in antibiotics and vaccines for pigs and poultry, with a maturing R&D pipeline and a global presence.